(Total Views: 641)
Posted On: 05/01/2020 7:58:29 PM
Post# of 153908
I anticipate that the FDA will next grant Gilead a 2-week combo trial with remdesivir and an anti-inflamatory, since CytoDyn has apparently rejected being involved.
And, I anticipate the FDA will quickly rubber stamp an approval. It's clear from Fauci's statements that this is the direction they are going.
And, I anticipate the FDA will quickly rubber stamp an approval. It's clear from Fauci's statements that this is the direction they are going.
(0)
(0)
